Acellular dermal matrix for chronic wound treatment: dry or wet?
The Ukrainian Biochemical Journal · 03.08.2026 · 98 (4) · 108-126
DOI: 10.15407/ubj98.04.108 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 03.08.2026. Verfasst von A. I. Dovhaliuk und 9 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic wounds pose a serious clinical and economic burden, and their effective treatment requires the development of new biomaterials that promote tissue regeneration. Acellular dermal matrices (ADMs) represent a promising regenerative strategy; however, their biological properties largely depend on the manufacturing protocol.
Objective
To compare the biocompatibility and cytotoxicity of two porcine acellular dermal matrix variants, dry (d-ADM) and wet (w-ADM), and to evaluate the therapeutic efficacy of the biocompatible matrix in an experimental porcine model of chronic full-thickness wounds.
Methods
Biocompatibility was assessed in vitro using human umbilical cord-derived mesenchymal stem cells (hU-MSCs) by evaluating cell morphology, viability, proliferation, and lactate dehydrogenase (LDH) release. The therapeutic efficacy of the selected ADM was investigated in a porcine chronic full-thickness excisional wound model and compared with non-adhesive dressings and Promogran Prisma. Wound healing was evaluated after 28 days using histological, immunohistochemical (TNF-α, TGF-β, Ki-67), and morphometric analyses.
Results
The wet ADM preserved hU-MSC morphology, viability, and proliferative capacity, whereas the dry ADM induced marked cytotoxicity, increased LDH release, and extensive cell death. In vivo, treatment with w-ADM significantly accelerated wound healing compared with both control dressings, resulting in complete and stable re-epithelialization, minimal inflammatory infiltration, organized collagen remodeling, and improved tissue architecture. Immunohistochemical analysis demonstrated significantly lower expression of TNF-α, TGF-β, and Ki-67, indicating resolution of inflammation and transition toward tissue remodeling and regenerative stabilization.
Conclusions
Wet acellular dermal matrix demonstrated excellent biocompatibility and superior regenerative performance, whereas the dry matrix exhibited unacceptable cytotoxicity. Wet ADM represents a promising scaffold for regenerative treatment of chronic wounds and warrants further investigation as a clinically applicable biomaterial, including in combination with mesenchymal stem cell-based therapies. Keywords: acellular dermal matrix, biocompatibility, chronic wounds, cytotoxicity, human umbilical mesenchymal stem cells, lyophilization, morphology
Zitieren
APA
Dovhaliuk, A. I., Kulianda, O. I., Ohinska, N. V., Redko, O. S., Kulianda, O. O., Kovalchuk, A. O., Kulbitska, V. V., Kramar, S. B., Korda, M. M., & Shevchuk, O. O. (2026). Acellular dermal matrix for chronic wound treatment: dry or wet?. The Ukrainian Biochemical Journal, 98(4), 108-126. https://doi.org/10.15407/ubj98.04.108
Vancouver
Dovhaliuk AI, Kulianda OI, Ohinska NV, Redko OS, Kulianda OO, Kovalchuk AO, et al. Acellular dermal matrix for chronic wound treatment: dry or wet?. The Ukrainian Biochemical Journal. 2026;98(4):108-126. doi:10.15407/ubj98.04.108
BibTeX
@article{Dovhaliuk2026,
author = {Dovhaliuk, A. I. and Kulianda, O. I. and Ohinska, N. V. and Redko, O. S. and Kulianda, O. O. and Kovalchuk, A. O. and Kulbitska, V. V. and Kramar, S. B. and Korda, M. M. and Shevchuk, O. O.},
title = {Acellular dermal matrix for chronic wound treatment: dry or wet?},
journal = {The Ukrainian Biochemical Journal},
year = {2026},
volume = {98},
number = {4},
pages = {108--126},
doi = {10.15407/ubj98.04.108}
}
EUVIMED